# An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption

> **NCT00217204** · PHASE2 · COMPLETED · sponsor: **McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.** · enrollment: 18 (actual)

## Conditions studied

- Cystic Fibrosis
- Steatorrhea

## Interventions

- **DRUG:** Pancrelipase microtablets

## Key facts

- **NCT ID:** NCT00217204
- **Lead sponsor:** McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2011-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00217204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00217204, "An Effectiveness, Safety, and Palatability Study of Pancrelipase Microtablets in Infants and Toddlers With Cystic Fibrosis and Fat Malabsorption". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00217204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*